Gleevec Label Updated With Cardiovascular Risk Language

Letter to physicians notes a small chance for CHF and left ventricular dysfunction with imatinib exists, but patients with or at risk for cardiac disease should be closely monitored.

More from Archive

More from Pink Sheet